Dymista^® Knowledge

Allergic rhinitis has an impact on patients, not just in the summer months, but all year round. In fact, 59% of moderate-severe allergic rhinitis patients have persistent symptoms,¹ which have an impact on their daily activities.² A study has shown that 74% of perennial allergic rhinitis sufferers have a moderate to…

We have recently highlighted how allergic rhinitis affects patients sleep, but what affect does this have on work productivity and school performance? As you can imagine, it can have a lasting impact. In fact, as a result of...

In a randomised, double-blind, placebo-controlled, 2-week trial involving 779 patients with moderate-to-severe seasonal allergic rhinitis...

Dymista^® leads to greater symptom improvement than using either azelastine or fluticasone propionate alone.¹

Dymista^® is suitable for long-term use For perennial allergic rhinitis patients to get the futl therapeutic benefit, regular use of treatment is essential. With Dymista^®, the duration of treatment should correspond to the period of allergenic exposure and...

It is important to remember that Dymista^® contains two active ingredients, fluticasone propionate, an intranasal steroid and azelastine an intranasal antihistamine. Antihistamines work quickly to alleviate the immediate symptoms of..